Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B

ConclusionsMatrine may be used to treat prostate cancer patients to increase the levels of GADD45B to inhibit tumor invasion and improve patient survivals.

Source: The Prostate - January 22, 2018 Category: Urology & Nephrology Authors: Hai Huang, Qiong Wang, Tao Du, Chunhao Lin, Yiming Lai, Dingjun Zhu, Wanhua Wu, Xiaoming Ma, Soumin Bai, Zean Li, Leyuan Liu, Qi Li Tags: ORIGINAL ARTICLE Source Type: research